INSIGNIA FINANCIAL LTD (ASX:IFL) - IFL's best days are ahead - do not sell into the storm, 56513214, page-39 - HotCopper | ASX Share Prices, Stock Market & Share Trading Forum

Originally posted by gragou02: ↑

Can someone tell me why IFL keeps dropping

There was a strong drop in the SP back in the early part of 2020 when the price dropped below $3 for a short period. Since then the price has slowly recovered and has recently meandered between $4 and $4.50.
This lack of direction in the price can, I think, be put down to the fact that there is no comfort in the eyes of the institutions, or anyone else for that matter, as to what this company will be worth going forward.

The reason for that is convoluted but essentially began when the Royal Commission came along and made substantial changes to the Investment Advisory business. The number of changes are too many to detail here but suffice to say it carved a big hole in the industry business model and caused a lot of the big players to head for the Exits. (Not being able to charge dead people for advice not given, seemed to be a bit of a bummer).

But rather than leave the game with the others, IFL decided to buy out a couple of the “exiters” to become just about the biggest funds manager/advisor in the country. The plan would be to enable the economies of scale that ensue from the takeovers to overcome the probable reduction in revenue resulting from the rule changes.Well, that’s the plan and it may well work.

The problem is that it’s not clear yet and won’t be for some time.

The first issue is that much of the costs linked to the transition have occurred early in the transition process while the benefits of the acquisitions won’t be seen for some time to come. And some elements of the business which had previously contributed profit are now discontinued as management seeks to streamline the business.

This issue is made more discomforting because the share value has been diluted after the allocation of shares to pay for the two acquisitions means that future profits will be distributed across 649m shares rather than 351m shares prior to the acquisitions.

Trying to measure the likely outcome of the transition based upon the 2021 financial results proved to be next to impossible. The statutory result reflected a loss of $142m compared to the profit for 2020 of $142m.

When the results were normalized the 2020 result reflected a profit of $128m while the 2021 result showed a profit improvement to $148m.But even working with the normalized result isn’t conclusive given that the 2020 result contained only 7 months of input from the ANZ takeover while 2021 had 12 months of benefit from the ANZ. The 2021 result also included one month of NAB income while 2020 of course didn’t contain any.

So an evaluation of a reasonable SP after the merge is completed will continue to be clouded because costs of the merge are still being incurred while the benefits of the merge are still to come to fruition.I heard the CEO being interviewed recently and in response to a question about when a real understanding of the outcome of such major changes would be known and better understood, he suggested that it’s not likely to be readily visible inside the 2022 accounts but that the full 2023 year will be the first time the picture becomes really clear.

I might add that he presumably has a clear picture of the future now while it’s the 2023 accounts which will provide the first insight for the external investors.

So I would not expect the SP to provide a strong path in any direction for quite a while.

Expand

Well there are many possibilities of what may or may not influence the share price , but let me ask you one question . If you were a reasonable sized buyer / fund manager etc , ( who in the main influence pricing ) and saw a company that looked “ good “ how would you accumulate it’s shares ?

Would you keep buying day after day , pushing what you want even higher ??
Maybe jus maybe you would do the exact opposite ?? jus a remote possibility , I know , I know ........

imho.

No.	Vol.	Price($)
2	11924	$2.28

No.

Vol.

Price($)

11924

$2.28

Price($)	Vol.	No.
$2.29	14923	2

Price($)

Vol.

No.

$2.29

14923

No.	Vol.	Price($)
1	9000	2.280
3	25252	2.270
4	32050	2.260
4	46008	2.250
1	5479	2.240

No.

Vol.

Price($)

9000

2.280

25252

2.270

32050

2.260

46008

2.250

5479

2.240

Price($)	Vol.	No.
2.300	97003	12
2.310	37715	4
2.320	66164	8
2.330	58182	9
2.340	61729	5

Price($)

Vol.

No.

2.300

97003

2.310

37715

2.320

66164

2.330

58182

2.340

61729

(20min delay)
Last $2.29		Change 0.000(0.00%)		Mkt cap ! $1.535B

Open	High	Low	Value	Volume
$2.30	$2.32	$2.28	$3.844M	1.673M

Well there are many possibilities of what may or may not...

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Microcap Wrap: 5 explorers with news out today

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Pointerra wins US$1.63M from US Dept of Energy to model climate change scenarios

Recce's R327 found effective against E.coli during clinical trial

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Ava Risk Group expands US presence with A$0.7M Substation Deal

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Well there are many possibilities of what may or may not...

Top Stories

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Microcap Wrap: 5 explorers with news out today

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Pointerra wins US$1.63M from US Dept of Energy to model climate change scenarios

Recce's R327 found effective against E.coli during clinical trial

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Ava Risk Group expands US presence with A$0.7M Substation Deal

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News